Cytokines, tumor necrosis factor-α and interleukin-1β, differentially regulate apoptosis in osteoarthritis cultured human chondrocytes

Osteoarthritis and Cartilage

Volumn 14, Issue 7, 2006, Pages 660-669

  Lopez Armada M J ^a   Carames B ^a   Lires Dean M ^a   Cillero Pastor, B ^a   Ruiz Romero, C ^a   Galdo, F ^a   Blanco, F J ^a  

^a HOSPITAL JUAN CANALEJO   (Spain)

Author keywords

Apoptosis; Caspase 8; Chondrocytes; Interleukin 1 ; Prostaglandin E2; Tumor necrosis factor

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE; CASPASE 3; CASPASE 7; CASPASE 8; CASPASE 8 INHIBITOR; CYTOKINE; DACTINOMYCIN; INDOMETACIN; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; MESSENGER RNA; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PROSTAGLANDIN E2; PROTEIN BCL 2; PROTEIN MCL 1; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CARTILAGE CELL; CELL VIABILITY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME DEGRADATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION; HIP OSTEOARTHRITIS; HUMAN; HUMAN CELL; HUMAN TISSUE; MODULATION; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; PROTEIN SYNTHESIS; RIBONUCLEASE PROTECTION ASSAY; WESTERN BLOTTING;

APOPTOSIS; CARTILAGE, ARTICULAR; CASPASES; CHONDROCYTES; CYTOKINES; DINOPROSTONE; HUMANS; INTERLEUKIN-1BETA; NITRIC OXIDE; OSTEOARTHRITIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745044261     PISSN: 10634584     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.joca.2006.01.005     Document Type: Article

References (42)

1. Lotz M., Blanco F.J., von Kempis J., Dudler J., Maier R., Villiger P.M., et al. Cytokine regulation of chondrocyte functions. J Rheumatol Suppl 43 (1995) 104-108
2. Fernandes J.C., Martel-Pelletier J., and Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 39 (2002) 237-246
3. Hashimoto J., Yoshikawa H., Takaoka K., Shimizu N., Masuhara K., Tsuda T., et al. Inhibitory effects of tumor necrosis factor alpha on fracture healing in rats. Bone 10 6 (1989) 453-457
4. Webb G.R., Westacott C.I., and Elson C.J. Chondrocyte tumor necrosis factor receptors and focal loss of cartilage in osteoarthritis. Osteoarthritis Cartilage 5 6 (1997) 427-437
5. Goldring M.B. Osteoarthritis and cartilage: the role of cytokines. Curr Rheumatol Rep 2 (2000) 459-465
6. Zhang X., Mao Z., and Yu C. Suppression of early experimental osteoarthritis by gene transfer of interleukin-1 receptor antagonist and interleukin-10. J Orthop Res 22 4 (2004) 742-750
7. Goldring M.B. Anticytokine therapy for osteoarthritis. Expert Opin Biol Ther 1 5 (2001) 817-829
8. Abramson S.B., and Amin A. Blocking the effects of IL-1 in rheumatoid arthritis protects bone and cartilage. Rheumatology (Oxford) 41 (2002) 972-980
9. Kühn K., Hashimoto S., and Lotz M. IL-1β protects human chondrocytes from CD95-induced apoptosis. J Immunol 164 (2000) 2233-2239
10. Fischer B.A., Mundle S., and Cole A.A. Tumor necrosis factor-alpha induced DNA cleavage in human articular chondrocytes may involve multiple endonucleolytic activities during apoptosis. Microsc Res Tech 50 (2000) 236-242
11. López-Armada M.J., Caramés B., Martin M.A., Fuentes-Boquete I., Cillero-Pastor B., Lires-Deán M., et al. Mitochondrial activity is modulated by tumour necrosis factor and interleukin-1 in human normal chondrocytes. (Abstract). Arthritis Rheum 50 9 (2004) 288
12. Relic B., Bentires-Alj M., Ribbens C., Franchimont N., Guerne P.A., Benoit V., et al. TNF-α protects human primary articular chondrocytes from nitric oxide-induced apoptosis via nuclear factor-kappaB. Lab Invest 82 12 (2002) 1661-1672
13. Kim H.A., and Song Y.W. TNF-α-mediated apoptosis in chondrocytes sensitized by MG132 or actinomycin D. Biochem Biophys Res Commun 295 (2002) 937-944
14. Park Y.W., Ji J.D., Lee J.S., Ryang D.W., and Yoo D.H. Actinomycin D renders cultured synovial fibroblasts susceptible to tumour necrosis factor related apoptosis-inducing ligand (TRAIL)-induced apoptosis. Scand J Rheumatol 32 (2003) 356-363
15. Jones B.E., Lo C.R., Srinivasan A., Streetz K., Valentino K.L., and Czaja M.J. Hepatocytes sensitized to tumour necrosis factor α cytotoxicity undergo apoptosis through caspase-dependent and caspase-independent pathways. J Biol Chem 275 (2000) 705-712
16. Dolcet X., Llobet D., Pallares J., Rue M., Comella J.X., and Matias-Guiu X. FLIP is frequently expressed in endometrial carcinoma and has a role in resistance to TRAIL-induced apoptosis. Lab Invest 85 (2005) 885-894
17. Kim H.A., Kim Y.H., and Song Y.W. Facilitation of Fas mediated apoptosis of human chondrocytes by the proteasome inhibitor and actinomycin D. J Rheumatol 30 (2003) 550-558
18. Kim H.H., and Kim K. Enhancement of TNFα-mediated cell death in vascular smooth muscle through cytochrome c-independent pathway by the proteasome inhibitor. FEBS Lett 535 (2003) 190-194
19. Kim P.K., Wang Y., Gambotto A., Kim Y.M., Weller R., Zuckerbraun B.S., et al. Hepatocyte Fas-associating death domain protein/mediator of receptor-inducing toxicity (FADD/MORT1) levels increase in response to pro-apoptotic stimuli. J Biol Chem 277 (2002) 38855-38862
20. López-Armada M.J., Caramés B., Cillero-Pastor B., Lires-Deán M., Maneiro E., Fuentes I., et al. Phosphatase-1 and 2 A inhibits apoptosis in human osteoarthritis chondrocytes independently of nitric oxide production. Ann Rheum Dis 64 7 (2005) 1079-1082
21. Yoon J.B., Kim S.J., Hwang S.G., Chang S., Kang S.S., and Chun J.S. Non-steroidal anti-inflammatory drugs inhibit nitric oxide-induced apoptosis and dedifferentiation of articular chondrocytes independent of cyclooxygenase activity. J Biol Chem 278 17 (2003) 15319-15325
22. Chomczynski P., and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162 (1987) 156-159
23. Blanco F.J., Ochs R.L., Schwarz H., and Lotz M. Chondrocyte apoptosis induced by nitric oxide. Am J Pathol 146 1 (1995) 75-85
24. Maneiro E., Lopez-Armada M.J., de Andres M.C., Carames B., Martin M.A., Bonilla A., et al. Effect of nitric oxide on mitochondrial respiratory activity of human articular chondrocytes. Ann Rheum Dis 64 3 (2005) 388-395
25. Notoya K., Jovanovic D.V., Reboul P., Martel-Pelletier J., Mineau F., and Pelletier J.P. The induction of cell death in human osteoarthritis chondrocytes by nitric oxide is related to the production of prostaglandin E2 via the induction of cyclooxygenase-2. J Immunol 165 6 (2000) 3402-3410
26. Blanco F.J., Guitian R., Vazquez-Martul E., de Toro F.J., and Galdo F. Osteoarthritis chondrocytes die by apoptosis. A possible pathway for osteoarthritis pathology. Arthritis Rheum 41 2 (1998) 284-289
27. Maneiro E., Martin M.A., de Andres M.C., Lopez-Armada M.J., Fernandez-Sueiro J.L., del Hoyo P., et al. Mitochondrial respiratory activity is altered in osteoarthritic human articular chondrocytes. Arthritis Rheum 48 3 (Mar 2003) 700-708
28. Kühn K., and Lotz M. Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes. Arthritis Rheum 44 7 (2001) 1644-1653
29. Kobayashi T., Okamoto K., Kobata T., Hasunuma T., Sumida T., and Nishioka K. Tumor necrosis factor α regulation of the FAS-mediated apoptosis-signalling pathway in synovial cells. Arthritis Rheum 42 3 (1999) 519-526
30. Amin A.R., Attur M., Patel R.N., Thakker G.D., Marshall P.J., Rediske J., et al. Superinduction of cyclooxygenase-2 activity in human osteoarthritis-affected cartilage. Influence of nitric oxide. J Clin Invest 99 6 (1997) 1231-1237
31. Ben-Av P., Crofford L.J., Wilder R.L., and Hla T. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: a potential mechanism for inflammatory angiogenesis. FEBS Lett 372 1 (1995) 83-87
32. Martel-Pelletier J., Pelletier J.P., and Fahmi H. Cyclooxygenase-2 and prostaglandins in articular tissues. Semin Arthritis Rheum 33 3 (2003) 155-167
33. Geng Y., Blanco F.J., Cornelisson M., and Lotz M. Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol 155 2 (1995) 796-801
34. Blanco F.J., Guitian R., Moreno J., de Toro F.J., and Galdo F. Effect of anti-inflammatory drugs on COX-1 and COX-2 activity in human articular chondrocytes. J Rheumatol 26 6 (1999) 1366-1373
35. DiBattista J.A., Martel-Pelletier J., Cloutier J.M., and Pelletier J.P. Modulation of glucocorticoid receptor expression in human articular chondrocytes by cAMP and prostaglandins. J Rheumatol Suppl 27 (1991) 102-105
36. Chrysis D., Zaman F., Chagin A.S., Takigawa M., and Savendahl L. Dexamethasone induces apoptosis in proliferative chondrocytes through activation of caspases and suppression of the Akt-phosphatidylinositol 3′kinase signaling pathway. Endocrinology 146 3 (2005) 1391-1397
37. Chan T.A., Morin P.J., Vogelstein B., and Kinzler K.W. Mechanisms underlying nonsteroidal anti-inflammatory drug-mediated apoptosis. Proc Natl Acad Sci U S A 95 2 (1998) 681-686
38. Kohli M., Yu J., Seaman C., Bardelli A., Kinzler K.W., Vogelstein B., et al. SMAC/Diablo-dependent apoptosis induced by nonsteroidal antiinflammatory drugs (NSAIDs) in colon cancer cells. Proc Natl Acad Sci U S A 101 48 (2004) 16897-16902
39. Relic B., Benoit V., Franchimont N., Ribbens C., Kaiser M.J., Gillet P., et al. 15-Deoxy-delta12,14-prostaglandin J2 inhibits Bay 11-7085-induced sustained extracellular signal-regulated kinase phosphorylation and apoptosis in human articular chondrocytes and synovial fibroblasts. J Biol Chem 279 21 (2004) 22399-22403
40. 12,14-prostaglandin J2 for induction of human articular chondrocyte apoptosis in arthritis. J Biol Chem 279 36 (2004) 37939-37950
41. Pettersen I., Figenschau Y., Olsen E., Bakkelund W., Smedsrod B., and Sveinbjornsson B. Tumor necrosis factor-related apoptosis-inducing ligand induces apoptosis in human articular chondrocytes in vitro. Biochem Biophys Res Commun 296 3 (2002) 671-676
42. Cho T.J., Lehmann W., Edgar C., Sadeghi C., Hou A., Einhorn T.A., et al. Tumor necrosis factor alpha activation of the apoptotic cascade in murine articular chondrocytes is associated with the induction of metalloproteinases and specific pro-resorptive factors. Arthritis Rheum 48 10 (2003) 2845-2854